---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-004572"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-05-31T23:58:02.693523+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma gets Nasdaq bid-price extension to Aug 26, 2024

## Summary
- Received Nasdaq Hearings Panel exception until August 26, 2024 to regain minimum bid price compliance.
- Must achieve closing bid price of at least $1.00 for 10 consecutive business days by deadline.
- Company was previously notified of deficiency under Listing Rule 5550(a)(2).
- Failure to meet conditions may result in delisting from Nasdaq.

## SEC filing metadata
- accession: 0001683168-24-004572
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316824004572/0001683168-24-004572-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316824004572/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-004572
- JSON: https://secwatch.observer/filing/0001683168-24-004572.json
- Plain text: https://secwatch.observer/filing/0001683168-24-004572.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.